Updates
ASAM Applauds Launch of HRSA SUD Treatment and Recovery Loan Repayment Program
The American Society of Addiction Medicine (ASAM) recently applauded the Health Resources and Services Administration (HRSA) for launching a new program that will encourage more medical students and health care professionals to pursue a career treating addiction at a...
Evaluation of Resident Physicians’ Knowledge of and Attitudes Towards Prescribing Buprenorphine for Patients with OUD
This study evaluated internal medicine (IM) residents’ knowledge of, attitudes towards, and barriers to prescribing buprenorphine for opioid use disorder (OUD). More than 160 residents were surveyed to assess demographics, knowledge base, and perceptions about using...
Growing Racial/Ethnic Disparities in Buprenorphine Distribution in the U.S.
Increasing the number of buprenorphine waivered prescribers has been a key strategy in increasing buprenorphine access. This study assessed whether per capita buprenorphine distribution varied by regional racial/ethnic composition, Medicaid expansion status, and time...
Drug Overdose Deaths Up 30% in Pandemic Year
Deaths from all types of drug overdoses increased by a staggering 30% over a one-year period, Nora Volkow, MD, Director of the National Institute on Drug Abuse (NIDA), reported at the FDA Science Forum. Data from the National Center for Health Statistics from October...
Systematic Review of Stigma Interventions for Providers Who Treat Patients with SUDs
The stigma surrounding substance use disorders (SUDs) is a frequently cited barrier to treatment engagement and there has been more interest about this in recent years. This study reviewed stigma interventions for providers and found several brief and effective...
Patient Pocket Guide for Opioid Addiction Treatment Now in Spanish
The American Society of Addiction Medicine (ASAM) created two resources so physicians treating addiction can access the ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use anytime, anywhere – and now it is...
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Save the Date! More information will be posted on our website as it is available.
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Learn more about our conferences and educational opportunities
Addiction Medicine Spring and Fall Conferences provide up-to-date substance use related education, applicable across general medical as well as addiction specialty practices.